Bosede Babalola-Adejokun
Psychiatric/Mental Health · Orlando, FLNPI 1659989549
Payments from drug & device makers
Across 216 payments — averaging $27.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$796
- Neurocrine Biosciences, Inc.$280
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$186
- plus $556 from 9 others
What the payments were for
- Food & beverage$5,90698%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 67 | $1,775 |
| Alkermes, Inc. | 44 | $1,406 |
| Otsuka America Pharmaceutical, Inc. | 47 | $1,006 |
| AbbVie | 29 | $796 |
| Neurocrine Biosciences, Inc. | 6 | $280 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $186 |
| Indivior Inc. | 6 | $143 |
| Axsome Therapeutics, Inc. | 2 | $132 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Ironshore Pharmaceuticals Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
| Corium, LLC | 2 | $30 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,309
- ARISTADA$1,003
- INVEGA SUSTENNA$479
- ARISTADA INITIO$251
- VRAYLAR$222
- INGREZZA$135
- QELBREE$125
- ABILIFY MAINTENA$118
- Auvelity$113
- CAPLYTA$101
How this compares
$6,006 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 12 | $1,206 |
| Divalproex Sodium ErDivalproex Sodium | 21 | $415 |
| Olanzapine | 19 | $209 |
| Hydroxyzine Pamoate | 19 | $169 |
| Quetiapine Fumarate | 20 | $133 |
| Mirtazapine | 13 | $97 |
| Trazodone Hcl | 23 | $68 |
| Sertraline Hcl | 11 | $38 |
| Amlodipine Besylate | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Orlando
- Elizabeth GueldeOrlando$48K
- Amber SiegelOrlando$17K
- Orville MurrayOrlando$13K
- Roger RiveraKissimmee$1.6M
- Bethanie Simmons BecilJacksonville$782K
- Hannah PhillipsMaitland$455K
- Cheedy JajaTampa$266K
- Scott DurrancePensacola$224K
- Eudaldo AponteHialeah$214K
- Heather WarrenTallahassee$172K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.